Evidence map›Paper›PMID 42129115›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Assessing the Tautomerase Activity of MIF Using L-Dopachrome.

Katie Treasure, Amanda Genders, James Harris

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katie TreasureDepartment of Nutrition, Dietetics and Food, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia. katie.treasure@monash.edu.
Amanda GendersDepartment of Nutrition, Dietetics and Food, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
James HarrisBiomedical Manufacturing, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine implicated in the pathogenesis of multiple acute and chronic inflammatory conditions, harbours diverse catalytic activity, notably the ability to tautomerize 2-carboxy-2,3-dihydroxyindole-5,6-quinone (L-dopachrome) to its dihydroxyindole derivative. While an endogenous substrate for this tautomerase activity is yet to be fully characterized, it is possible MIF enzymatic activity is important for numerous biological functions. As a result, assessing the tautomerase activity of MIF may serve as a useful screening tool for identifying small-molecule MIF inhibitors. This chapter details the use of a simple, cell-free, spectrophotometric assay for investigating the inhibitory potential of small-molecule compounds against the keto-enol tautomerase activity of MIF.

Indexed as

Enzyme AssaysIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsCell-Free SystemEnzyme InhibitorsHumansSpectrophotometryEnzyme InhibitorsIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsCytokinesMacrophage migration inhibitory factorSmall-molecule inhibitorsTautomerase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.